Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Growth hormone deficiency is associated with decreased quality of life in patients with prior acromegaly.

Wexler T, Gunnell L, Omer Z, Kuhlthau K, Beauregard C, Graham G, Utz AL, Biller B, Nachtigall L, Loeffler J, Swearingen B, Klibanski A, Miller KK.

J Clin Endocrinol Metab. 2009 Jul;94(7):2471-7. doi: 10.1210/jc.2008-2671. Epub 2009 Apr 14.

2.

Effect of growth hormone replacement therapy on the quality of life in women with growth hormone deficiency who have a history of acromegaly versus other disorders.

Valassi E, Brick DJ, Johnson JC, Biller BM, Klibanski A, Miller KK.

Endocr Pract. 2012 Mar-Apr;18(2):209-18. doi: 10.4158/EP11134.OR.

3.

Growth hormone status predicts left ventricular mass in patients after cure of acromegaly.

Wexler TL, Durst R, McCarty D, Picard MH, Gunnell L, Omer Z, Fazeli P, Miller KK, Klibanski A.

Growth Horm IGF Res. 2010 Oct;20(5):333-7. doi: 10.1016/j.ghir.2010.05.003. Epub 2010 Jul 3.

4.

Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement.

Miller KK, Wexler T, Fazeli P, Gunnell L, Graham GJ, Beauregard C, Hemphill L, Nachtigall L, Loeffler J, Swearingen B, Biller BM, Klibanski A.

J Clin Endocrinol Metab. 2010 Feb;95(2):567-77. doi: 10.1210/jc.2009-1611. Epub 2010 Jan 8.

5.

Influences on quality of life in GH deficient adults and their effect on response to treatment.

Murray RD, Skillicorn CJ, Howell SJ, Lissett CA, Rahim A, Smethurst LE, Shalet SM.

Clin Endocrinol (Oxf). 1999 Nov;51(5):565-73.

PMID:
10594517
6.

GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiency.

Giavoli C, Profka E, Verrua E, Ronchi CL, Ferrante E, Bergamaschi S, Sala E, Malchiodi E, Lania AG, Arosio M, Ambrosi B, Spada A, Beck-Peccoz P.

J Clin Endocrinol Metab. 2012 Nov;97(11):3983-8. doi: 10.1210/jc.2012-2477. Epub 2012 Aug 17.

PMID:
22904173
7.

GH deficiency in patients after cure of acromegaly by surgery alone.

Yamada S, Fukuhara N, Nishioka H, Takeshita A, Suzuki H, Miyakawa M, Takeuchi Y.

Eur J Endocrinol. 2011 Dec;165(6):873-9. doi: 10.1530/EJE-11-0657. Epub 2011 Sep 30.

8.

Assessment of quality of life in adults receiving long-term growth hormone replacement compared to control subjects.

Malik IA, Foy P, Wallymahmed M, Wilding JP, MacFarlane IA.

Clin Endocrinol (Oxf). 2003 Jul;59(1):75-81.

PMID:
12807507
10.

Effects of growth hormone deficiency on body composition and biomarkers of cardiovascular risk after definitive therapy for acromegaly.

Lin E, Wexler TL, Nachtigall L, Tritos N, Swearingen B, Hemphill L, Loeffler J, Biller BM, Klibanski A, Miller KK.

Clin Endocrinol (Oxf). 2012 Sep;77(3):430-8. doi: 10.1111/j.1365-2265.2012.04361.x.

11.

The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults.

Woodhouse LJ, Mukherjee A, Shalet SM, Ezzat S.

Endocr Rev. 2006 May;27(3):287-317. Epub 2006 Mar 16. Review.

PMID:
16543384
12.

Psychological effects of withdrawal of growth hormone therapy from adults with growth hormone deficiency.

McMillan CV, Bradley C, Gibney J, Healy ML, Russell-Jones DL, Sönksen PH.

Clin Endocrinol (Oxf). 2003 Oct;59(4):467-75.

PMID:
14510909
13.

Neurobehavioral and quality of life changes associated with growth hormone insufficiency after complicated mild, moderate, or severe traumatic brain injury.

Kelly DF, McArthur DL, Levin H, Swimmer S, Dusick JR, Cohan P, Wang C, Swerdloff R.

J Neurotrauma. 2006 Jun;23(6):928-42.

PMID:
16774477
14.

Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.

Lagrou K, Xhrouet-Heinrichs D, Massa G, Vandeweghe M, Bourguignon JP, De Schepper J, de Zegher F, Ernould C, Heinrichs C, Malvaux P, Craen M.

J Pediatr Endocrinol Metab. 2001;14 Suppl 5:1249-60; discussion 1261-2.

PMID:
11964020
15.
16.

Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.

Ahmad AM, Hopkins MT, Thomas J, Ibrahim H, Fraser WD, Vora JP.

Clin Endocrinol (Oxf). 2001 Jun;54(6):709-17.

PMID:
11422104
17.

Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis.

Tritos NA, Johannsson G, Korbonits M, Miller KK, Feldt-Rasmussen U, Yuen KC, King D, Mattsson AF, Jonsson PJ, Koltowska-Haggstrom M, Klibanski A, Biller BM.

J Clin Endocrinol Metab. 2014 Jun;99(6):2018-29. doi: 10.1210/jc.2014-1013. Epub 2014 Apr 2.

PMID:
24694339
18.

Sweat secretion rates in growth hormone disorders.

Sneppen SB, Main KM, Juul A, Pedersen LM, Kristensen LO, Skakkebaek NE, Feldt-Rasmussen U.

Clin Endocrinol (Oxf). 2000 Nov;53(5):601-8.

PMID:
11106921
19.

Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.

Marzullo P, Di Somma C, Pratt KL, Khosravi J, Diamandis A, Lombardi G, Colao A, Rosenfeld RG.

J Clin Endocrinol Metab. 2001 Jul;86(7):3001-8.

PMID:
11443159
20.

Ghrelin test for the assessment of GH status in successfully treated patients with acromegaly.

Pekic S, Doknic M, Miljic D, Joksimovic M, Glodic J, Djurovic M, Dieguez C, Casanueva F, Popovic V.

Eur J Endocrinol. 2006 May;154(5):659-66.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk